Market Research Report Store Kolon Life Science Inc (102940) - Pharmaceuticals

Market Research Report Store has been recently published a fresh report"Kolon Life Science Inc (102940) - Pharmaceuticals & Healthcare - Deals and Alliances Profile-Market Research Report Store＂.It is a professional and in-depth study. Complete Report Available at: @ https://www.marketresearchreportstore.com/ Request a sample, click here [email protected] Description Kolon Life Science Inc (KLS) carries out research and development, manufacture and commercialization of pharmaceutical products and active pharmaceutical ingredients (APIs). It develops innovative cell and gene therapeutics. The company's lead product is Invossa, first cell-mediated gene therapy for osteoarthritis. KLS' product portfolio includes biopharmaceuticals, APIs, antimicrobials and water treatment solutions. Its technology platform produces and utilizes protein for human body by performing gene manipulation and cell culturing technology. The company’s cell-mediated gene therapies are used in degenerative diseases. It offers anti-bacterial agents for cosmetic, paint and other industries and water treatment agents. KLS is headquartered in Gwachun-si, Gyunggi-do, South Korea. Kolon Life Science Inc (102940) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. Scope